Data / New clinical trials / Autoimmune Diseases

Autoimmune Diseases trials: 150 new since Nov 2024

Name: New Autoimmune Diseases clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Autoimmune Diseases clinical trials: 150 rows for $7.50, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 5 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/autoimmune-diseases, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated October 30, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

150 clinical studies in Autoimmune Diseases were first posted on ClinicalTrials.gov from November 12, 2024 to October 30, 2026; 64 have an industry sponsor and 122 are recruiting or about to. The newest, NCT07906145, was posted on October 30, 2026: A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases (Shanghai Qilu Pharmaceutical Research and Development Center LTD).

The request: Every new Autoimmune Diseases clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

150New trials
64Industry sponsored
122Recruiting or not yet
October 30, 2026Latest posted

Newest trials

The newest 100 of 150, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
October 30, 2026	NCT07906145	A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases	Shanghai Qilu Pharmaceutical Research and Development Center LTD	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Primary Sjögren's Syndrome (pSS), Systemic Sclerosis (SSc)	76		clinicaltrials.gov
October 29, 2026	NCT07902817	A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy	Jade Biosciences, Inc.	Phase 3	Recruiting	IgA Nephropathy (IgAN)	480	United States	clinicaltrials.gov
October 29, 2026	NCT07902687	A Clinical Study to Evaluate the Safety and Effectiveness of MSCohi-O Lens in the Treatment of Immune-related Ocular Surface Diseases.	Guangdong ProCapZoom Biosciences Co., Ltd.	Phase 1	Not yet recruiting	Keratitis, Autoimmunity, Dry Eye Disease (DED)	20		clinicaltrials.gov
October 21, 2026	NCT07885605	Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease	Ethyreal Bio, Inc.	Phase 1	Recruiting	Thyroid Eye Disease (TED), Graves' Disease, Eye Diseases, Hereditary, Eye Diseases, Exophthalmos, Orbital Diseases...	72	United States	clinicaltrials.gov
October 14, 2026	NCT07873931	A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases	Bristol-Myers Squibb	Phase 1	Not yet recruiting	Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic...	60	Belgium, France, Germany, Netherlands, Poland, United States	clinicaltrials.gov
October 8, 2026	NCT07865442	First in Human Study of ALT-01 in Healthy Participants	Altis Medicines, Inc	Phase 1	Not yet recruiting	Autoimmune Disease	50	Australia	clinicaltrials.gov
October 6, 2026	NCT07861828	Exploratory Study of the Efficacy of HuMoSCs (Human Monocyte-derived Suppressor Cells) on Glandular Involvement in Sjögren's Syndrome	Centre Hospitalier Universitaire Dijon	Not applicable	Not yet recruiting	Sjogren's Syndrome, Autoimmune Diseases	20	France	clinicaltrials.gov
October 2, 2026	NCT07854483	C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory...	AbelZeta Inc.	Phase 1	Not yet recruiting	Systemic Sclerosis (SSc), Systemic Sclerosis, Systemic Sclerosis (Scleroderma), Systemic Sclerosis - 2013 ACR/EULAR...	12	United States	clinicaltrials.gov
October 1, 2026	NCT07853378	Incidence and Predictors of Early Clinical Relapse Within Six Months After Thymectomy in Patients With Myasthenia Gravis	Assiut University	Observational	Not yet recruiting	Myasthenia Gravis, Thymoma	30		clinicaltrials.gov
September 23, 2026	NCT07835685	Glycemic Control and Quality of Life Evolution for Patients With T1D Using the myLoop Powered by CamAPS FX System in Combination With...	mylife Diabetes Care AG	Observational	Not yet recruiting	Diabetes Type 1	220		clinicaltrials.gov
September 3, 2026	NCT07802665	Capillary Sampling in Clinical Populations Undergoing Monitoring	University of Edinburgh	Observational	Not yet recruiting	Chronic Kidney Disease, Autoimmune Diseases, Solid Organ Transplant Recipients	1,000		clinicaltrials.gov
September 2, 2026	NCT07799116	Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus Nephritis	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	Phase 1/2	Recruiting	Lupus Nephritis, Lupus Nephritis (LN)	10	Spain	clinicaltrials.gov
August 25, 2026	NCT07784400	Inflammation, Autoimmunity and Healthy Ageing in Menopause Transition. An Observational, Cross-sectional Study	Fondazione IRCCS Policlinico San Matteo di Pavia	Observational	Not yet recruiting	Autoimmune Diseases, Menopause	300	Italy	clinicaltrials.gov
August 21, 2026	NCT07779616	Study of PTC844 in Participants With Active Rheumatoid Arthritis	PTC Therapeutics	Phase 2	Recruiting	Rheumatoid Arthritis	75	Georgia, Mauritius, South Africa, United States	clinicaltrials.gov
August 21, 2026	NCT07778446	A Study to Test CRT-402 in Refractory Autoimmune Disease	Myeloid Therapeutics	Phase 1/2	Recruiting	Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Scleroderma, Myositis	34	Australia	clinicaltrials.gov
August 12, 2026	NCT07759115	Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study	University of Texas at Austin	Not applicable	Recruiting	Multiple Sclerosis, Pathologic Processes, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous...	64	United States	clinicaltrials.gov
July 31, 2026	NCT07738822	A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA	Cullinan Therapeutics Inc.	Phase 1/2	Not yet recruiting	Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)	72	United States	clinicaltrials.gov
July 29, 2026	NCT07734675	Sociocognitive Intervention and Rehabilitation Program in Multiple Sclerosis	Sonia Batista	Not applicable	Not yet recruiting	Multiple Sclerosis	130	Portugal	clinicaltrials.gov
July 28, 2026	NCT07732309	A Study of ATG-201 in Adult Participants With Autoimmune Diseases	Antengene Biologics Limited	Phase 1	Recruiting	Systemic Lupus Erythematosus, Systemic Sclerosis (SSc), Sjogren's Disease, Autoimmune Diseases	149	China	clinicaltrials.gov
July 28, 2026	NCT07730723	The Effect of Nicorandil on Rheumatoid Arthritis Patients	Ain Shams University	Phase 2/3	Recruiting	Rheumatoid Arthritis (RA)	70	Egypt	clinicaltrials.gov
July 28, 2026	NCT07729826	C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Lupus Nephritis Refractory to...	AbelZeta Inc.	Phase 2	Not yet recruiting	Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases	50		clinicaltrials.gov
July 13, 2026	NCT07699380	METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)	University of Washington	Phase 2	Recruiting	Type 1 Diabetes (T1D), Metabolic Diseases, Glucose Metabolism Disorders, Endocrine System Diseases, Autoimmune...	60	Netherlands, United States	clinicaltrials.gov
July 13, 2026	NCT07697274	Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial	Medical University of South Carolina	Early phase 1	Not yet recruiting	Systemic Sclerosis, Sclerodactyly	10	United States	clinicaltrials.gov
July 13, 2026	NCT07697118	Study Evaluating a Gene Therapy for IPEX Syndrome Through the Expression of FOXP3 on Deficient T Cells to Produce Tregs-like.	Assistance Publique - Hôpitaux de Paris	Phase 1/2	Not yet recruiting	The Immune Dysregulation Polyendocrinopathy Enteropathy X-linked Syndrome is a Primary Immunodeficiency Caused by...	5	France	clinicaltrials.gov
July 10, 2026	NCT07695727	Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes	IRCCS San Raffaele	Observational	Not yet recruiting	Type 1 Diabetes, Autoimmunity	84	Italy	clinicaltrials.gov
July 1, 2026	NCT07679412	Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.	LucasBio	Not applicable	Recruiting	CMV Retinitis	5	South Korea	clinicaltrials.gov
June 29, 2026	NCT07674147	RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases	The Children's Hospital of Zhejiang University School of Medicine	Early phase 1	Not yet recruiting	Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory...	30	China	clinicaltrials.gov
June 22, 2026	NCT07659704	CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus	University of Sao Paulo	Phase 1/2	Not yet recruiting	Lupus Erythematosus, Systemic	16	Brazil	clinicaltrials.gov
June 17, 2026	NCT07655453	Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005	Starna Therapeutics	Not applicable	Not yet recruiting	Relapsed/Refractory Autoimmune Diseases	36		clinicaltrials.gov
June 16, 2026	NCT07650565	Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)	University Hospital, Montpellier	Not applicable	Recruiting	Systemic Sclerosis (SSc)	16	France	clinicaltrials.gov
June 16, 2026	NCT07649265	A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 1	Recruiting	Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Sjögren's Disease	63	Australia	clinicaltrials.gov
June 9, 2026	NCT07636876	The Italian Multiple Sclerosis and Related Disorders Register	Fondazione Italiana Sclerosi Multipla	Observational	Enrolling by invitation	Multiple Sclerosis, Neuromyelitis Optica, Demyelinating Diseases of the Central Nervous System, Myelin Oligodendrocyte...	96,000	Italy	clinicaltrials.gov
June 5, 2026	NCT07629596	Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B...	Circunited BioPharma (Shenzhen) Co., Ltd.	Early phase 1	Recruiting	Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia (AIHA)	5	China	clinicaltrials.gov
June 2, 2026	NCT07621809	Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease...	Novartis Pharmaceuticals	Phase 3	Recruiting	Sjögren´s Disease	570	Australia, Austria, Brazil, Canada, China, Colombia, Czechia, France, Germany...	clinicaltrials.gov
May 29, 2026	NCT07614412	SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.	Ministry of Health, Saudi Arabia	Phase 2	Not yet recruiting	Type 1 Diabetes Mellitus	240	Saudi Arabia	clinicaltrials.gov
May 29, 2026	NCT07613411	Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases	Chinese PLA General Hospital	Early phase 1	Not yet recruiting	Autoimmune Diseases	60	China	clinicaltrials.gov
May 26, 2026	NCT07605637	Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005	Beijing GoBroad Hospital	Not applicable	Not yet recruiting	Relapsed/Refractory Autoimmune Diseases	18		clinicaltrials.gov
May 22, 2026	NCT07604792	FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.	Beijing Boren Hospital	Early phase 1	Withdrawn	Autoimmune Diseases	0	China	clinicaltrials.gov
May 14, 2026	NCT07586267	CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	Early phase 1	Recruiting	Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy...	15	China	clinicaltrials.gov
May 13, 2026	NCT07583030	A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Early phase 1	Withdrawn	Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE), Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)...	0	China	clinicaltrials.gov
April 27, 2026	NCT07552987	A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome	Kedrion S.p.A.	Phase 3	Not yet recruiting	Stiff Person Syndrome	38		clinicaltrials.gov
April 21, 2026	NCT07541287	A Study of JADE101 in Participants With Immunoglobulin A Nephropathy	Jade Biosciences, Inc.	Phase 2	Recruiting	IgA Nephropathy	30	Australia, New Zealand, South Korea, Taiwan, United States	clinicaltrials.gov
April 13, 2026	NCT07524244	Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis	Fuller Research Foundation	Not applicable	Recruiting	Rheumatoid Arthritis (RA), Crohn's Disease (CD), Ulcerative Colitis (UC)	160	United States	clinicaltrials.gov
April 13, 2026	NCT07523282	Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases	Shenzhen MagicRNA Biotechnology Co., Ltd	Phase 1	Not yet recruiting	Autoimmune Disease, Systemic Lupus Erythematosus, Systemic Sclerosis (SSc)	12	China	clinicaltrials.gov
April 8, 2026	NCT07517575	Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis	R-Pharm International, LLC	Phase 2	Recruiting	Juvenile Idiopathic Arthritis	71	Russia	clinicaltrials.gov
April 7, 2026	NCT07515638	Immun4Cure Cohort of Autoimmune Diseases	University Hospital, Montpellier	Observational	Recruiting	Rheumatoid Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Healthy Adult Volunteers	500	France	clinicaltrials.gov
April 6, 2026	NCT07513181	Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely...	Athos Therapeutics Inc	Phase 2	Recruiting	Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases	120	United States	clinicaltrials.gov
April 2, 2026	NCT07507201	Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	Early phase 1	Recruiting	Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy...	15	China	clinicaltrials.gov
March 31, 2026	NCT07503366	Standardized Italian netwoRk Enrolling iNdividuals With Islet-Autoantibodies	Società Italiana di Endocrinologia e Diabetologia Pediatrica	Observational	Not yet recruiting	Type 1 Diabetes (T1D), Autoantibodies, Hyperglycemia, Impaired Glucose Tolerance (Prediabetes)	300	Italy	clinicaltrials.gov
March 25, 2026	NCT07492550	The T1DWATCH Study: a Screening for Type 1 Diabetes Autoantibodies in Children for Early Detection and Intervention.	Fabiana Sherine Ganem dos Santos	Observational	Not yet recruiting	Diabete Type 1	2,200		clinicaltrials.gov
March 24, 2026	NCT07490951	A Clinical Study of the Safety, Tolerability and Preliminary Efficacy of CD19/BCMA-targeted CAR-T Therapy in Refractory Autoimmune Diseases	Liang Zou	Not applicable	Recruiting	Autoimmune Diseases	20	China	clinicaltrials.gov
March 16, 2026	NCT07472166	Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	Phase 4	Completed	Scleroderma, Systemic	34	Bangladesh	clinicaltrials.gov
March 13, 2026	NCT07470151	Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	Not applicable	Recruiting	System Lupus Erythematosus(SLE), Scleroderma, Myasthenia Gravis (MG)	12	China	clinicaltrials.gov
March 6, 2026	NCT07455578	Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease	Seismic Therapeutic AU Pty Ltd	Phase 1	Recruiting	Autoimmune Diseases, Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Psoriasis (PsO), Cutaneous Lupus...	24	Australia	clinicaltrials.gov
March 4, 2026	NCT07448298	A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases	Beijing Boren Hospital	Early phase 1	Withdrawn	Relapsed/Refractory Autoimmune Diseases	0	China	clinicaltrials.gov
February 25, 2026	NCT07432334	CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus	Vinmec Research Institute of Stem Cell and Gene Technology	Phase 1	Recruiting	Refractory Systemic Lupus Erythematosus	8	Vietnam	clinicaltrials.gov
February 20, 2026	NCT07424027	Central Vein Sign in Multiple Sclerosis Extension Study	The Cleveland Clinic	Not applicable	Recruiting	Multiple Sclerosis	40	United States	clinicaltrials.gov
February 13, 2026	NCT07408336	Clinical Study of AFN50 Injection in the Autoimmune Diseases	AlphaNa Bioscience Company Limited	Early phase 1	Recruiting	Autoimmune Diseases	18	China	clinicaltrials.gov
February 10, 2026	NCT07400757	Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease	Taipei Veterans General Hospital, Taiwan	Not applicable	Recruiting	Thyroid Eye Disease, TED, Graves Ophthalmopathy	120	Taiwan	clinicaltrials.gov
February 5, 2026	NCT07391046	Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Observational	Not yet recruiting	Chronic Disease, Immunocompromised, HIV Infection, Chronic Kidney Disease, Solid Organ Transplantation, Hematopoietic...	1,500		clinicaltrials.gov
February 5, 2026	NCT07388212	Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases	West China Hospital	Early phase 1	Not yet recruiting	Autoimmune Diseases	27		clinicaltrials.gov
January 26, 2026	NCT07366866	A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.	Changchun GeneScience Pharmaceutical Co., Ltd.	Phase 1	Recruiting	Autoimmune Disease	56	China	clinicaltrials.gov
January 23, 2026	NCT07363954	To Evaluate the Safety and Tolerability of STR-P004 for the Treatment of Immune-mediated Kidney Diseases	Starna Therapeutics	Not applicable	Not yet recruiting	Autoimmune Diseases	9		clinicaltrials.gov
January 23, 2026	NCT07362758	Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases	Xinqiao Hospital of Chongqing	Early phase 1	Not yet recruiting	Autoimmune Diseases	47		clinicaltrials.gov
January 23, 2026	NCT07362654	Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease	Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud	Not applicable	Recruiting	Celiac Disease, Gluten Sensitivity, Autoimmune Diseases	51	Spain	clinicaltrials.gov
January 20, 2026	NCT07349823	Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection	West China Hospital	Early phase 1	Not yet recruiting	Autoimmune Diseases	47		clinicaltrials.gov
January 16, 2026	NCT07348432	The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes	McGill University	Observational	Recruiting	Insulin Dependent Diabetes Mellitus, Feeding and Eating Disorders, Eating Behavior, Type 1 Diabetes, Autoimmune...	106	Canada	clinicaltrials.gov
January 15, 2026	NCT07343115	Familial Systemic Scleroderma	University Hospital, Strasbourg, France	Observational	Recruiting	Systemic Scleroderma	20	France	clinicaltrials.gov
January 9, 2026	NCT07328581	A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis	iCell Gene Therapeutics	Phase 2	Recruiting	Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)	20	United States	clinicaltrials.gov
January 7, 2026	NCT07322718	Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases	Ruijin Hospital	Early phase 1	Recruiting	Relapsed/Refractory B Cell-Mediated Autoimmune Diseases	27	China	clinicaltrials.gov
December 26, 2025	NCT07305116	CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease	The Children's Hospital of Zhejiang University School of Medicine	Phase 1	Recruiting	Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy...	15	China	clinicaltrials.gov
December 16, 2025	NCT07284797	A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases	Xencor, Inc.	Phase 1	Recruiting	Healthy, Idiopathic Inflammatory Myopathies, Systemic Sclerosis, Sjögren's Disease	60	Australia	clinicaltrials.gov
December 15, 2025	NCT07283315	Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related...	The Children's Hospital of Zhejiang University School of Medicine	Early phase 1	Recruiting	Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR	12	China	clinicaltrials.gov
December 4, 2025	NCT07264517	Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).	Instituto Grifols, S.A.	Phase 2	Completed	Dry Eye Disease	103	United States	clinicaltrials.gov
December 3, 2025	NCT07260942	Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus	University Hospital, Bordeaux	Not applicable	Recruiting	Systemic Lupus Erythematosus	120	France	clinicaltrials.gov
November 28, 2025	NCT07252791	Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases	University of Sao Paulo General Hospital	Phase 4	Recruiting	Autoimmune Rheumatologic Disease	114	Brazil	clinicaltrials.gov
November 24, 2025	NCT07246096	Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory...	Changhai Hospital	Early phase 1	Recruiting	Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Sclerosis, Primary Sjögren Syndrome, Rheumatoid Arthritis...	60	China	clinicaltrials.gov
October 28, 2025	NCT07221890	A Trial of Academic Detailing to Promote Prescribing of Biosimilars	Brigham and Women's Hospital	Not applicable	Active not recruiting	Autoimmune Diseases, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD), Psoriasis (PsO)	1,325	United States	clinicaltrials.gov
October 28, 2025	NCT07221565	Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)	Truway Health, Inc.	Phase 1/2	Enrolling by invitation	Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis, Autoimmune Diseases, Chronic Inflammatory...	120	United States	clinicaltrials.gov
October 3, 2025	NCT07205861	Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center	Assistance Publique - Hôpitaux de Paris	Observational	Recruiting	Thrombotic Thrombocytopenic Purpura (TTP), Immune Thrombotic Thrombocytopenic Purpura, Thrombotic Microangiopathies...	1,200	France	clinicaltrials.gov
September 26, 2025	NCT07193667	CAR-T in Subjects With Relapsed/Refractory Autoimmune Disease	ShenZhen Cell Valley	Not applicable	Recruiting	Relapsed/Refractory Autoimmune Diseases	3	China	clinicaltrials.gov
September 23, 2025	NCT07188844	An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Immunovant Sciences GmbH	Phase 2	Terminated	Chronic Inflammatory Demyelinating Polyneuropathy	26	Argentina, Belgium, Brazil, Germany, Greece, Italy, Poland, Romania, Serbia...	clinicaltrials.gov
September 23, 2025	NCT07188285	Mass Spectrometry-based Immune Profiling in Autoimmune Diseases	Peking University People's Hospital	Observational	Enrolling by invitation	Systemic Lupus Erthematosus, Sjogren's Syndrome, Inflammatory Myopathies, Systemic Sclerosis (SSc), Vasculitis...	500	China	clinicaltrials.gov
September 19, 2025	NCT07182227	PS-002 for the Treatment of IgA Nephropathy in Adults	Purespring Therapeutics Limited	Phase 1/2	Recruiting	Immunoglobulin A (IgA) Nephropathy	32	United Kingdom, United States	clinicaltrials.gov
September 16, 2025	NCT07175610	LUpus Eritematoso Sistemico NETwork and Registry	Società Italiana di Allergologia, Asma e Immunologia Clinica	Observational	Not yet recruiting	Systemic Lupus Erythematous (SLE)	1,500	Italy	clinicaltrials.gov
September 16, 2025	NCT07174843	An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases	Shanghai Cell Therapy Group Co.,Ltd	Early phase 1	Recruiting	Idiopathic Inflammatory Myopathies(IIM), Immune Thrombocytopenia(ITP), Systemic Lupus Erythematosus(SLE)	20	China	clinicaltrials.gov
September 15, 2025	NCT07171983	A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis	Bristol-Myers Squibb	Phase 1	Recruiting	Rheumatoid Arthritis	46	India	clinicaltrials.gov
September 8, 2025	NCT07161193	Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases	Hebei Senlang Biotechnology Inc., Ltd.	Phase 1/2	Not yet recruiting	Autoimmune Diseases	30	China	clinicaltrials.gov
September 8, 2025	NCT07159893	Inectolizumab With Steroid Optimization in Newly Treated NMOSD	First Affiliated Hospital of Wenzhou Medical University	Not applicable	Not yet recruiting	Neuromyelitis Optica, Autoimmune Diseases, Demyelinating Autoimmune Diseases, CNS	25		clinicaltrials.gov
August 27, 2025	NCT07143617	Exploratory Clinical Study on the Safety of STR-P004	Beijing GoBroad Hospital	Not applicable	Recruiting	Autoimmune Diseases	39	China	clinicaltrials.gov
August 14, 2025	NCT07123519	A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases	China Immunotech (Beijing) Biotechnology Co., Ltd.	Phase 1	Recruiting	Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Sjogren's Syndrome (SS), Inflammatory Myopathy...	18	China	clinicaltrials.gov
August 14, 2025	NCT07122076	GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases	Grit Biotechnology	Early phase 1	Recruiting	Autoimmune Diseases	10	China	clinicaltrials.gov
August 13, 2025	NCT07121777	Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases	Anhui Provincial Hospital	Not applicable	Recruiting	Autoimmune Diseases	18	China	clinicaltrials.gov
August 11, 2025	NCT07115745	A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	Phase 1	Recruiting	Refractory Autoimmune Diseases	125	Australia, Brazil, Czechia, France, Germany, Israel, Poland, Romania, Spain...	clinicaltrials.gov
August 6, 2025	NCT07105735	RN1201 Injection for Autoimmune Diseases Refractory to Standard Therapies	The First Affiliated Hospital with Nanjing Medical University	Phase 1	Recruiting	Autoimmune Diseases Refractory to Standard Therapies	18	China	clinicaltrials.gov
August 5, 2025	NCT07104721	A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases	China Immunotech (Beijing) Biotechnology Co., Ltd.	Phase 1	Recruiting	Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Systemic Sclerosis (SSc), Inflammatory Myopathy...	18	China	clinicaltrials.gov
August 5, 2025	NCT07103746	Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	Recruiting	Autoimmune Disorders	30	United States	clinicaltrials.gov
July 31, 2025	NCT07095075	A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases	Nanjing Legend Biotech Co.	Early phase 1	Recruiting	Relapsed/Refractory Autoimmune Diseases	36	China	clinicaltrials.gov
July 25, 2025	NCT07085104	A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease	Allogene Therapeutics	Phase 1	Recruiting	Systemic Lupus Erythematosus (With and Without Nephritis), Idiopathic Inflammatory Myopathy, Systemic Sclerosis	66	Canada, United States	clinicaltrials.gov
July 15, 2025	NCT07065955	Longevity Diet and the Fasting-mimicking Diet	Fondazione Valter Longo	Observational	Completed	Overweight, Obesity, Metabolic Syndrome, Autoimmune Diseases, Inflammatory Disease, Health, Subjective	365	Italy	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
The Children's Hospital of Zhejiang University School of Medicine	6	June 29, 2026
Beijing Boren Hospital	4	May 22, 2026
Beijing GoBroad Hospital	3	May 26, 2026
Immunovant Sciences GmbH	3	September 23, 2025
First Affiliated Hospital of Wenzhou Medical University	3	September 8, 2025
Anhui Provincial Hospital	3	August 13, 2025
Nanjing Legend Biotech Co.	3	July 31, 2025
Jade Biosciences, Inc.	2	October 29, 2026
Bristol-Myers Squibb	2	October 14, 2026
AbelZeta Inc.	2	October 2, 2026
Fondazione IRCCS Policlinico San Matteo di Pavia	2	August 25, 2026
Assistance Publique - Hôpitaux de Paris	2	July 13, 2026
Starna Therapeutics	2	June 17, 2026
University Hospital, Montpellier	2	June 16, 2026
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	June 16, 2026
Novartis Pharmaceuticals	2	June 2, 2026
Chinese PLA General Hospital	2	May 29, 2026
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	2	May 13, 2026
Kedrion S.p.A.	2	April 27, 2026
West China Hospital	2	February 5, 2026

By phase

Phase	New trials	Latest
Not applicable	30	October 6, 2026
Phase 1	28	October 30, 2026
Observational	25	October 1, 2026
Early phase 1	25	July 13, 2026
Phase 2	17	August 21, 2026
Phase 1/2	12	September 2, 2026
Phase 3	8	October 29, 2026
Phase 4	4	March 16, 2026
Phase 2/3	1	July 28, 2026

By country

Country	New trials	Latest
China	47	July 28, 2026
United States	39	October 29, 2026
Australia	14	October 8, 2026
France	13	October 14, 2026
Spain	13	September 2, 2026
Italy	13	August 25, 2026
Germany	10	October 14, 2026
Poland	9	October 14, 2026
United Kingdom	9	June 2, 2026
South Korea	7	July 1, 2026
Romania	7	September 23, 2025
Czechia	6	June 2, 2026
Argentina	6	September 23, 2025
Netherlands	5	October 14, 2026
Brazil	5	June 22, 2026
Greece	5	September 23, 2025
Belgium	4	October 14, 2026
Canada	4	June 2, 2026
Hungary	4	June 2, 2026
Taiwan	4	June 2, 2026
Serbia	4	September 23, 2025
Turkey (Türkiye)	4	July 10, 2025
Bulgaria	4	April 29, 2025
Georgia	3	August 21, 2026
Croatia	3	June 27, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.